János Szlávik, chief infectious disease specialist of the South Pest Central Hospital, spoke about the coronavirus. Szlávik believes that the waves of epidemics mostly consist of an ascending phase and a short stagnation followed by a descending phase. Hungary is currently in the ascending phase.
The number of people infected with the coronavirus has been steadily rising in recent days. Szlávik also pointed out that there were way more restrictions when the figures were this bad in March. However, an important difference is that there were not that many vaccinated people back then. The Hungarian Government decided not to impose further restrictions probably because it took into account the high vaccination rate.
Although, we do not know what to expect in the future. Many are afraid that there will be further restrictions at Christmas time.
“I do not think anyone can say that, because the number of cases that we have now is very high, so it is also conceivable that the numbers will drop by Christmas time,”
said Szlávik. The government has been organising a vaccination action week to prevent the coronavirus epidemic from deteriorating.
Szlávik believes that it would be important to introduce new restrictions. Due to limited capacity of the Hungarian health care system, the number of infected people must not increase further. According to Szlávik, the use of the protection card has become more and more widespread. Consequently, the number of people who choose to get vaccinated has been also rising.
“After all, if we restrict an unvaccinated person in his daily life, sooner or later he will be compelled to take the vaccine so that he can continue his everyday life with the same normality as before.”
Vaccinations take time to develop protection. Therefore, whoever wants to be vaccinated should go for vaccination as soon as possible. In addition, it is important to mention that the coronavirus vaccine and the flu shot can be taken at the same time, writes index.hu.
Szlávik also mentioned the anti-coronavirus medicine. There are two pills that are in the third phase of research, said the infectious disease specialist on TV2. Based on current tests, both drugs prove to be effective. They are especially useful to treat mild to moderate symptoms. According to the preliminary studies, one of the pills, that was manufactured by Pfizer, is 89 percent effective for prevention of hospitalization and death.